Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza
- 22 October 2009
- journal article
- Published by Wiley in Respirology
- Vol. 14 (8), 1173-1179
- https://doi.org/10.1111/j.1440-1843.2009.01639.x
Abstract
The antiviral neuraminidase inhibitor oseltamivir (OSV) is used to treat influenza. The macrolide clarithromycin (CAM) is used to treat bacterial infections and has anti-inflammatory and immunomodulatory activities. This retrospective study investigated the immunomodulatory effects of CAM in children presenting with influenza A.The study recruited 40 children with acute influenza, and grouped them according to the treatment received: 5-day treatment with OSV (n = 14), CAM (n = 8), OSV + CAM (n = 12) and untreated (n = 6). The before and after treatment comparisons were made of the level of secretory IgA (sIgA) against influenza A virus (H3N2) and (H1N1), total sIgA, viral RNA copy numbers in nasopharyngeal aspirates and disease symptoms.Infection induced anti-viral mucosal sIgA in the nasopharyngeal aspirates of most patients of all treatment groups. Particularly prominent increases in the levels were found in the CAM and OSV + CAM groups. Low induction of anti-viral sIgA was observed in the OSV group, but the addition of CAM to OSV augmented sIgA production and restored local mucosal sIgA levels. The frequency of residual cough in the OSV + CAM group was significantly lower than in the other groups including the group treated with OSV.CAM boosted the nasopharyngeal mucosal immune response in children presenting with influenza A, even in those treated with OSV who had low production of mucosal anti-viral sIgA, and alleviated the symptoms of influenza.Keywords
This publication has 24 references indexed in Scilit:
- A T Cell-Dependent Mechanism for the Induction of Human Mucosal Homing Immunoglobulin A-Secreting PlasmablastsImmunity, 2009
- The regulation of IgA class switchingNature Reviews Immunology, 2008
- Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutantsNature, 2008
- Tamiflu and neuropsychiatric disturbance in adolescentsBMJ, 2007
- Oseltamivir and Delirious Behavior in Children With InfluenzaThe Pediatric Infectious Disease Journal, 2006
- Mucosal antibody response induced with a nasal virosome-based influenza vaccineVaccine, 2003
- Clarithromycin Inhibits NF-κB Activation in Human Peripheral Blood Mononuclear Cells and Pulmonary Epithelial CellsAntimicrobial Agents and Chemotherapy, 2001
- Intranasal Interleukin‐12 is a Powerful Adjuvant for Protective Mucosal ImmunityThe Journal of Infectious Diseases, 1999
- Anti-inflammatory activity of macrolides: a new therapeutic potential?Journal of Antimicrobial Chemotherapy, 1998
- Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivityEuropean Journal of Immunology, 1984